Mark McKenna is founder and CEO of Mirador Therapeutics, a company driving a new era in precision medicine for immune-mediated inflammatory and fibrotic diseases. He spoke with Dan Dees, co-head of Goldman Sachs Global Banking & Markets, about establishing a pace of innovation at Mirador that delivers novel medicines to patients faster. This session was filmed at our 2024 Builders and Innovators Summit.